February 2, 2026
1 min read

Abbott’s Exact Sciences Deal Recasts Diagnostics While Nutrition Faces Reset

Abbott Laboratories (NYSE:ABT) agreed to acquire Exact Sciences for US$21b. The deal is set to reshape Abbott’s diagnostics business by adding a broad cancer testing platform. Management is also rolling out changes in the Nutrition segment in response to ongoing operational challenges. For you as an investor, the Exact Sciences deal puts a spotlight on Abbott’s push deeper into cancer diagnostics, an area that continues to attract significant attention across healthcare. At the same time,…

Leave a Reply

Your email address will not be published.

Previous Story

What’s cooking at the Oaks Nutrition Centers in New Madrid and Portage…

Next Story

To fix ‘spiritual malaise’ behind addiction, Kennedy announces efforts on homelessness and recovery

Previous Story

What’s cooking at the Oaks Nutrition Centers in New Madrid and Portage…

Next Story

To fix ‘spiritual malaise’ behind addiction, Kennedy announces efforts on homelessness and recovery

Latest from Blog

Go toTop